RxDoctor Payments Data

Jason Bailey, PA

Medical · Roanoke, VANPI 1760567481

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.3% of the total across 476 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 26 manufacturers, the largest accounting for just 23.2% — the pattern of someone who eats at a lot of different presentations. Among medical clinicians in VA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$10,366in general payments, 2019–2025

Across 476 payments — averaging $21.78 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Johnson & Johnson$1K
  • Sanofi$629
  • Incyte Corporation$609
  • Hill Dermaceuticals, Inc.$580
  • Pfizer$580
  • plus $5K from 20 others

What the payments were for

  • Food & beverage$9,66993%
  • Education$6977%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$10,366 in reported general payments places this provider in the 95th percentile of 632 medical providers in Virginia.

See all medical providers in Virginia

Medicare billing

Part B allowed, 2024
$241,796
Medicare patients
1,309
Services billed
5,200

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Humira(Cf) PenAdalimumab30$378,597
Cosentyx Sensoready (2 Pens)Secukinumab24$198,520
Dupixent SyringeDupilumab21$78,297
Clobetasol Propionate287$16,016
Clindamycin Phosphate95$3,863
Metronidazole67$3,314
Tretinoin30$2,963
Ketoconazole171$2,502
Doxycycline Hyclate122$2,424
Triamcinolone Acetonide167$1,903
Nystatin116$1,760
Hydroxyzine Hcl98$728
Ciclopirox22$717
Betamethasone Dipropionate13$634
Ammonium Lactate40$589

Paid to pharmacies, not to this prescriber.

Other medical in Roanoke

See the full list for Virginia

Where these figures come from

Is this you, or does something look wrong? →